Author:
da Silva Camila Oliveira,Gicquel Thomas,Daniel Yoann,Bártholo Thiago,Vène Elise,Loyer Pascal,Pôrto Luís Cristóvão,Lagente Vincent,Victoni Tatiana
Abstract
AbstractCigarette smoke exposure (CS) is the main risk factor for chronic obstructive pulmonary disease (COPD). Macrophages have an important role in COPD because they release pro-inflammatory and anti-inflammatory cytokines. The present study’s we investigate the functional changes in macrophages and monocytes exposed to cigarette smoke extract (CSE). Herein, using human monocyte-derived macrophages (MDMs) from healthy donors and we found that CSE was not associated with significant changes in the production of pro inflammatory cytokines by MDMs. In contrast, exposure to CSE suppressed the production of IL-6 and Gro-a/CXCL1 by LPS-stimulated-MDMs, but had an additive effect on the release of IL-8/CXCL8 and MCP1/CCL2. However, CSE exposure was associated with greater production, TARC/CCL-17 and CCL22/MDC. Moreover, MDMs displayed a lower uptake capacity after CSE exposure. We identify, for what is to our knowledge the first time that monocytes from patients with COPD produced less IL-8/CXCL8 and Gro-α/CXCL1 after LPS stimulation and produced higher levels of TARC/CCL17 and MDC/CCL-22 after IL-4 stimulation. Our present results highlighted a skewed immune response, with an imbalance in M1 vs. M2 cytokine production. In conclusion, exposure to CS has contrasting, multifaceted effects on macrophages and monocytes. Our data may provide a better understanding of the mechanisms underlying COPD.
Funder
Coordenação de Aperfeiçoamento de Pessoal de NÃvel Superior
Institut National de la Santé et de la Recherche Médicale
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Vogelmeier, C. F. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Arch. Bronconeumol. 53, 128–149 (2017).
2. Global initiative for chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf.
3. Buhl, R. et al. Guideline for the diagnosis and treatment of asthma—Guideline of the German Respiratory Society and the German Atemwegsliga in cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology. Pneumologie 71, e3 (2017).
4. Barnes, P. J. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 138, 16–27 (2016).
5. Herr, C. et al. Suppression of pulmonary innate host defence in smokers. Thorax 64, 144–149 (2009).
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献